Moreover, profiling data of primary HL and control B-cells indicated reduced expression levels of MSX1, BCL11A and SPIB in HL patient samples, supporting their aberrant downregulation and hence their possible clinical relevance (Supplementary Figure 4, 5). Here, MSX1 is linked to Hodgkins lymphoma.